National Artificial Intelligence Application Shanghai Pilot Testing Base: Announces Five Major Core Innovation Achievements

Mars Finance News March 28 - The National Artificial Intelligence Application Shanghai Pilot Base held a conference on March 28 at Zhongshan Hospital affiliated with Fudan University to summarize its phased achievements, announcing five core innovative results and nine medical intelligent applications, significantly advancing the high-quality development of “Artificial Intelligence + Healthcare” in China. The five core phased achievements are: 1. Based on the construction of an integrated new computing power service platform covering computing, storage, networking, and development toolchains, a computing resource foundation is formed that connects “model development - validation iteration - inference service - security governance,” breaking through technical adaptation barriers, achieving “national models using national cores,” with performance on par with world-class computing power levels; 2. Launching six major vertical basic medical models, creating a fully stack autonomous and controllable multimodal large model matrix, covering diverse clinical scenarios such as imaging, pathology, traditional Chinese medicine, and scientific research, with several medical large models reaching internationally leading levels; 3. Establishing a national demonstrative medical AI data infrastructure, aggregating massive high-quality three medicine data, strengthening the core foundation for model training and iteration; 4. Creating a globally leading Chinese medical large model testing platform MedBench 4.0, establishing authoritative and unified industry evaluation standards; 5. Selecting and promoting world-class medical intelligent applications across multiple disciplines and scenarios, accelerating the rapid deployment of cutting-edge technologies from laboratories to clinical frontlines. This conference also highlighted the release of nine medical intelligent applications, covering clinical diagnosis and treatment, device research and development, AI pharmaceuticals, brain-machine interfaces, and more. So far, the Shanghai Pilot Base has launched several intelligent systems for cardiovascular disease “Guanxin,” liver and gallbladder tumors, chest imaging one scan multiple checks, gold coding staff, and hospital-wide electronic medical record generation. Among them, the liver and gallbladder tumor intelligent system has been promoted to 122 medical institutions, serving over one million people; the chest imaging one scan multiple checks intelligent system has processed over 2.5 million cases, covering more than 20 hospitals nationwide, significantly improving clinical efficiency and diagnostic accuracy. The National Artificial Intelligence Application Shanghai Pilot Base (in the medical field) is a key carrier for implementing national strategies and building a global hub for medical AI applications, promoting the transition of medical AI from individual breakthroughs to system integration. (CCTV News)